The evaluation of a telephonic wellness coaching intervention for weight reduction and wellness improvement in a community-based cohort of persons with serious mental illness

Journal of Nervous and Mental Disease

Volumn 201, Issue 11, 2013, Pages 977-986

  Temmingh, Henk ^a   Claassen, Amanda ^b   Van Zyl, Sandi ^b   Carrara, Henri ^c   Dayakalashe, Nyameka Matross ^a   Myer, Landon ^c   Stein, Dan J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Virgin Life Care (Pty) Ltd   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Lifestyle coaching; Serious mental illness; Telephonic; Weight reduction; Wellness improvement

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CAREGIVER; CHRONIC DISEASE; CLINICAL EVALUATION; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL PATIENT; METABOLIC SYNDROME X; MOOD DISORDER; OUTPATIENT; SCHIZOPHRENIA; TELEMEDICINE; TELEPHONIC WELLNESS COACHING INTERVENTION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WELLBEING;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX; TELEMEDICINE; WEIGHT LOSS; YOUNG ADULT;

EID: 84887702790     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0000000000000036     Document Type: Article

References (75)

1. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndromeVA new worldwide definition. Lancet. 366:1059-1062
2. Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE (2009) Obesity among those with mental disorders: A National Institute of Mental Health meeting report. Am J Prev Med. 36:341-350
3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th edYtext rev). Washington, DC: American Psychiatric Association
4. American Psychiatric Association, American Diabetes Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 65:267-272
5. Bandura A (1986) Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall
6. Block G, Gillespie C, Rosenbaum EH, Jenson C (2000) A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med. 18:284-288
7. Bombardier CH, Bell KR, Temkin NR, Fann JR, Hoffman J, Dikmen S (2009) The efficacy of a scheduled telephone intervention for ameliorating depressive symptoms during the first year after traumatic brain injury. J Head Trauma Rehabil. 24:230-238
8. Bonfioli E, Berti L, Goss C, Muraro F, Burti L (2012) Health promotion lifestyle interventions for weight management in psychosis: A systematic review and meta-Analysis of randomised controlled trials. BMC Psychiatry. 12:78
9. Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R (2005) Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 66:205-212
10. Brown S (1997) Excess mortality of schizophrenia. A meta-Analysis. Br J Psychiatry. 171:502-508
11. Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med. 29:697-701
12. Castelnuovo G, Manzoni GM, Villa V, Cesa GL, Pietrabissa G, Molinari E (2011) The STRATOB study: Design of a randomized controlled clinical trial of cognitive behavioral therapy and brief strategic therapy with telecare in patients with obesity and binge-eating disorder referred to residential nutritional rehabilitation. Trials. 12:114
13. Centers for Disease Control and Prevention (2000) Measuring healthy days. CDC. Atlanta, GA: Centers for Disease Control & Prevention
14. Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE (2003) Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis. 191:799-805
15. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Mö ller HJ (2009a) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 24:412-424
16. De Hert M, Schreurs V, Vancampfort D, Van Winkel R (2009b) Metabolic syndrome in people with schizophrenia: A review. World Psychiatry. 8:15-22
17. De Hert MA, Van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J (2006) Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res. 83:87-93
18. Dickerson FB, Brown CH, Kreyenbuhl JA, Fang L, Goldberg RW, Wohlheiter K, Dixon LB (2006) Obesity among individuals with serious mental illness. Acta Psychiatr Scand. 113:306-313
19. Digenio AG, Mancuso JP, Gerber RA, Dvorak RV (2009) Comparison of methods for delivering a lifestyle modification program for obese patients: A randomized trial. Ann Intern Med. 150:255-262
20. Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A (1999) The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 187:496-502
21. Edelman D, Oddone EZ, Liebowitz RS, Yancy WS Jr, Olsen MK, Jeffreys AS, Moon SD, Harris AC, Smith LL, Quillian-Wolever RE, Gaudet TW (2006) A multidimensional integrative medicine intervention to improve cardiovascular risk. J Gen Intern Med. 21:728-734
22. EVans S, Newton R, Higgins S (2005) Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomized controlled trial. Aust N Z J Psychiatry. 39:479-486
23. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ (2005) Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for PennsylVanians. Bipolar Disord. 7:424-430
24. Faulkner G, Cohn T, Remington G (2007) Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev. CD005148
25. Frates EP, Moore MA, Lopez CN, McMahon GT (2011) Coaching for behavior change in physiatry. Am J Phys Med Rehabil. 90:1074-1082
26. Glanz K, Rimer BK, Iswanath K (2008) Health behavior and health education: Theory, research and practice. San Francisco: Jossey-Bass
27. Gorber SC, Tremblay M, Moher D, Gorber B (2007) A comparison of direct vs. self-report measures for assessing height, weight and body mass index: A systematic review. Obes Rev. 8:307-326
28. Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, Viinamaki HT (2006) Metabolic syndrome and depression: A cross-sectional analysis. J Clin Psychiatry. 67:1422-1427
29. Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 150:1115-1121
30. Holland SK, Greenberg J, Tidwell L, Malone J, Mullan J, Newcomer R (2005) Community-based health coaching, exercise, and health service utilization. J Aging Health. 17:697-716
31. Holt RI, Peveler RC (2006) Association between antipsychotic drugs and diabetes. Diabetes Obes Metab. 8:125-135
32. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:683-689
33. Kalarchian MA, Marcus MD, Levine MD, Haas GL, Greeno CG, Weissfeld LA, Qin L (2005) Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry. 66:1058-1063
34. Killackey E, Anda AL, Gibbs M, varez-Jimenez M, Thompson A, Sun P, Baksheev GN (2011) Using Internet enabled mobile devices and social networking technologies to promote exercise as an intervention for young first episode psychosis patients. BMC Psychiatry. 11:80
35. Komulainen T, Keranen AM, Rasinaho E, Hakko H, Savolainen MJ, Kujari ML, Reponen A, Lindeman S (2011) Quitting a weight loss program is associated with anhedonia: Preliminary findings of the Lifestyle Intervention Treatment Evaluation Study in northern Finland. Int J Circumpolar Health. 70:72-78
36. Kreyenbuhl J, Dickerson FB, Medoff DR, Brown CH, Goldberg RW, Fang L, Wohlheiter K, Mittal LP, Dixon LB (2006) Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis. 194:404-410
37. Kwon JS, Choi JS, Bahk WM, Yoon KC, Hyung KC, Chul SY, Park BJ, Geun OC (2006) Weight management program for treatment-emergent weight gain in olanzapine-Treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry. 67:547-553
38. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-Aged men. JAMA. 288:2709-2716
39. Lindenmayer JP, Khan A, Wance D, Maccabee N, Kaushik S, Kaushik S (2009) Outcome evaluation of a structured educational wellness program in patients with severe mental illness. J Clin Psychiatry. 70:1385-1396
40. Locke EA, Latham GP (2002) Building a practically useful theory of goal setting and task motivation. A 35-year odyssey. Am Psychol. 57:705-717
41. Lyketsos CG, Dunn G, Kaminsky MJ, Breakey WR (2002) Medical comorbidity in psychiatric inpatients: Relation to clinical outcomes and hospital length of stay. Psychosomatics. 43:24-30
42. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, SulliVan L, Meltzer HY, Hsiao J, Scott ST, Lieberman JA (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 80:19-32
43. McKay JR, Lynch KG, Shepard DS, Ratichek S, Morrison R, Koppenhaver J, Pettinati HM (2004) The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. J Consult Clin Psychol. 72:967-979
44. Merrill RM, Bowden DE, Aldana SG (2010) Factors associated with attrition and success in a worksite wellness telephonic health coaching program. Educ Health (Abingdon). 23:385
45. Meyer JM, Stahl SM (2009) The metabolic syndrome and schizophrenia. Acta Psychiatr Scand. 119:4-14
46. Miller BJ, Paschall CB III, Svendsen DP (2006) Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv. 57:1482-1487
47. Miller NH (2010) Motivational interviewing as a prelude to coaching in healthcare settings. J Cardiovasc Nurs. 25:247-251
48. Miller WR, Rollnick S (2002) Motivational interviewing: Preparing people for change. New York: The Guildford Press
49. Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M (2013a) Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-Analysis of first episode, untreated and treated patients. Schizophr Bull. 39:295-305
50. Mitchell AJ, Vancampfort D, Sweers K, Van Winkel R, Yu W, De Hert M (2013b) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disordersVA systematic review and meta-Analysis. Schizophr Bull. 39:306-318
51. Mulder H, Franke B, Van Der-Beek Van Der AA, Arends J, Wilmink FW, Egberts AC, Scheffer H (2007) The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: A cross-sectional study. Pharmacogenomics J. 7:318-324
52. Nihalani N, Schwartz TL, Siddiqui UA, Megna JL (2011) Weight gain, obesity, and psychotropic prescribing. J Obes. 2011:893629
53. O'Reilly R, Bishop J, Maddox K, Hutchinson L, Fisman M, Takhar J (2007) Is telepsychiatry equivalent to face-To-face psychiatry? Results from a randomized controlled equivalence trial. Psychiatr Serv. 58836-843
54. Osby U, Correia N, Brandt L, Ekbom A, Sparen P (2000) Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 45:21-28
55. Pasanisi F, Contaldo F, de SG, Mancini M (2001) Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis. 11:401-406
56. Petry NM, Barry D, Pietrzak RH, Wagner JA (2008) Overweight and obesity are associated with psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med. 70288-297
57. Piette JD, Richardson C, Himle J, Duffy S, Torres T, Vogel M, Barber K, Valenstein M (2011) A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care. 49:641-648
58. Pratt M, Sarmiento OL, Montes F, Ogilvie D, Marcus BH, Perez LG, Brownson RC (2012) The implications of megatrends in information and communication technology and transportation for changes in global physical activity. Lancet. 380:282-293
59. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A (2007) No health without mental health. Lancet. 370859-877
60. Resnicow K, DiIorio C, Soet JE, Ernst D, Borrelli B, Hecht J (2002) Motivational interviewing in health promotion: It sounds like something is changing. Health Psychol. 21:444-451
61. Richardson CR, Avripas SA, Neal DL, Marcus SM (2005) Increasing lifestyle physical activity in patients with depression or other serious mental illness. J Psychiatr Pract. 11:379-388
62. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M (2000) Definition and prevalence of severe and persistent mental illness. Br J Psychiatry. 177:149-155
63. Schwartz TL, Nihalani N, Jindal S, Virk S, Jones N (2004) Psychiatric medication-induced obesity: A review. Obes Rev. 5115-121
64. Shomaker LB, Tanofsky-Kraff M, Zocca JM, Field SE, Drinkard B, Yanovski JA (2012) Depressive symptoms and cardiorespiratory fitness in obese adolescents. J Adolesc Health. 50:87-92
65. StataCorp (2009) Stata statistical software: Release 11. College Station, TX: StataCorp LP.
66. Taylor DM, McAskill R (2000) Atypical antipsychotics and weight gainVA systematic review. Acta Psychiatr Scand. 101:416-432
67. Tulloch H, Reida R, D'Angeloa MS, Plotnikoff RC, Morrina L, Beatona L, Papadakisa S, Pipe A (2009) Predicting short and long-Term exercise intentions and behaviour in patients with coronary artery disease: A test of protection motivation theory. Psychol Health. 24255-269
68. Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, Ho BP, Newman RW, McNeil JJ (2003) Coaching patients On Achieving Cardiovascular Health (COACH): A multicenter randomized trial in patients with coronary heart disease. Arch Intern Med. 163:2775-2783
69. Vale MJ, Jelinek MV, Best JD, Santamaria JD (2002) Coaching patients with coronary heart disease to achieve the target cholesterol: A method to bridge the gap between evidence-based medicine and the ''real world''VRandomized controlled trial. J Clin Epidemiol. 55:245-252
70. Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L (2011) Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: A systematic review. Int J Behav Nutr Phys Act. 8:28
71. Vidal J (2002) Updated review on the benefits of weight loss. Int J Obes Relat Metab Disord. 26(suppl 4):S25-S28
72. Weiden PJ, Mackell JA, McDonnell DD (2004) Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res. 66:51-57
73. Wing RR, Jeffery RW (1999) Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. J Consult Clin Psychol. 67:132-138
74. Wolever RQ, Dreusicke M, Fikkan J, Hawkins TV, Yeung S, Wakefield J, Duda L, Flowers P, Cook C, Skinner E (2010) Integrative health coaching for patients with type 2 diabetes: A randomized clinical trial. Diabetes Educ. 36:629-639
75. Zarate CA Jr, Weinstock L, Cukor P, Morabito C, Leahy L, Burns C, Baer L (1997) Applicability of telemedicine for assessing patients with schizophrenia: Acceptance and reliability. J Clin Psychiatry. 58:22-25